Abstract

Ovarian, uterine, and cervical cancers collectively represent a significant burden on women's health worldwide. This comprehensive overview sheds light on the epidemiology, risk factors, early detection strategies, and treatment modalities for these gynecologic malignancies. Ovarian cancer, often diagnosed at advanced stages, poses challenges due to its nonspecific symptoms and lack of effective screening tools. Uterine cancer, primarily endometrial in origin, is associated with obesity, hormonal imbalances, and genetic predisposition. Cervical cancer, linked to human papillomavirus (HPV) infection, highlights the importance of vaccination and screening programs in reducing incidence and mortality rates. Early detection through Pap smears, HPV testing, transvaginal ultrasound, and molecular profiling is crucial for improving survival outcomes. Treatment approaches encompass surgery, chemotherapy, radiation therapy, and targeted therapies tailored to individual tumor characteristics. Advances in precision medicine, immunotherapy, and minimally invasive surgical techniques offer promising avenues for enhancing patient outcomes and quality of life. Through interdisciplinary collaboration, research endeavors, and public health initiatives, we aim to mitigate the impact of ovarian, uterine, and cervical cancers and improve the overall well-being of women affected by these diseases